Viewing Study NCT04566133


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-01-14 @ 2:24 PM
Study NCT ID: NCT04566133
Status: TERMINATED
Last Update Posted: 2023-08-21
First Post: 2020-09-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
Sponsor:
Organization: